The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Therachon AG / See Company Profile

Acquisition / Therachon scooped up by Pfizer / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 9, 2019

Acquisition / Therachon acquires GLyPharma / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 10, 2018

Financing / Series A brings in $12mm for newly created GLyPharma / Strategic Transactions / Deal Date: Oct. 1, 2012 / Publish Date: Oct. 10, 2018

ImmunGene Inc. / See Company Profile

Alliance / Spectrum gets rights to ImmunGene's IO platform and related assets / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 10, 2019

Financing / ImmunGene closes $9mm Series A / Strategic Transactions / Deal Date: Nov. 1, 2013 / Publish Date: Jul. 20, 2014

Alliance / Cephalon Australia to use ImmunGene’s technology on six cancer targets / Strategic Transactions / Deal Date: Jan. 1, 2011 / Publish Date: Jan. 26, 2011

NextCure Inc. / See Company Profile

Financing / NextCure's IPO nets $80.2mm / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 10, 2019

Alliance / Lilly and NextCure pen immuno-oncology deal / Strategic Transactions / Deal Date: Nov. 1, 2018 / Update Date: May 1, 2019

Financing / NextCure closes $93mm Series B round / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 15, 2018


Medical Devices

Email Alert | RSS Feed

Acelity LP Inc. / See Company Profile

Acquisition / 3M to buy Acelity; enterprise value $6.7bn / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 3, 2019

Acquisition / Acelity acquires Crawford Healthcare / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 12, 2018

Acquisition / Allergan acquires regenerative medicine company LifeCell / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 22, 2016

Ethicon Inc. / See Company Profile

Alliance / Takeda divests TachoSil to Ethicon / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 10, 2019

Acquisition / Advanced Sterilization Products to be acquired by Fortive for $2.7bn in cash / Strategic Transactions / Deal Date: Jun. 1, 2018 / Update Date: Apr. 1, 2019

Acquisition / Ethicon pays $3.4bn in cash for Auris Health / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Feb. 14, 2019

TransMedics Inc. / See Company Profile

Financing / Second IPO attempt successful for TransMedics; nets $97.4mm / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 3, 2019

Financing / Another late-stage round brings $51.2mm to TransMedics; $12.5mm added / Strategic Transactions / Deal Date: May 1, 2016 / Update Date: Jul. 1, 2016

Financing / Late-stage round brings $20mm to TransMedics / Strategic Transactions / Deal Date: Jun. 1, 2015 / Publish Date: Jun. 15, 2015


In Vitro Diagnostics

Email Alert | RSS Feed

Meridian Bioscience Inc. / See Company Profile

Acquisition / Meridian Bioscience buys GenePOC / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: May 6, 2019

Financing / PNC, Fifth Third provide Meridian Bio with up to $125mm in debt facility / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: May 6, 2019

Alliance / DiaSorin, Meridian sign second agreement for Liaison platform / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 24, 2018

Veracyte Inc. / See Company Profile

Financing / Public offering nets $138mm for Veracyte / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 7, 2019

Alliance / J&J, Veracyte ally in lung cancer diagnostics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Financing / Public offering nets $55.4mm for Veracyte / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 27, 2018


Pharmaceuticals

Email Alert | RSS Feed

Immunomedics Inc. / See Company Profile

Alliance / Everest Medicines licenses exclusive sacituzumab rights from Immunomedics / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 30, 2019

Alliance / Immunomedics to promote Janssen Biotech's erdafitinib in the US / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 30, 2019

Alliance / Immunomedics and AZ/MedImmune enter trial collaboration / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 24, 2018

Mitsubishi Tanabe Pharma Corp. / See Company Profile

Alliance / Salix gets rights to Mitsubishi Tanabe's MT1303 / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 30, 2019

Alliance / Mitsubishi Tanabe Pharma gets US rights to AnGes' Phase III Collategene; later expands rights / Strategic Transactions / Deal Date: Jul. 1, 2012 / Update Date: Apr. 1, 2019

Alliance / Mitsubishi Tanabe gets Japanese rights to Invossa from Kolon / Strategic Transactions / Deal Date: Nov. 1, 2016 / Update Date: Dec. 1, 2017

Mustang Bio Inc. / See Company Profile

Financing / Public offering nets $29.7mm for Mustang Bio / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 2, 2019

Financing / Mustang Bio enters $20mm venture debt financing with Horizon, gets $15mm up front / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 29, 2019

Alliance / Mustang Bio enters rare disease gene therapy space through partnership with St. Jude Children's / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 17, 2018

Biotechnology

Biotechnology

Email Alert | RSS Feed

Therachon AG / See Company Profile

Acquisition / Therachon scooped up by Pfizer / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 9, 2019

Acquisition / Therachon acquires GLyPharma / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 10, 2018

Financing / Series A brings in $12mm for newly created GLyPharma / Strategic Transactions / Deal Date: Oct. 1, 2012 / Publish Date: Oct. 10, 2018

ImmunGene Inc. / See Company Profile

Alliance / Spectrum gets rights to ImmunGene's IO platform and related assets / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 10, 2019

Financing / ImmunGene closes $9mm Series A / Strategic Transactions / Deal Date: Nov. 1, 2013 / Publish Date: Jul. 20, 2014

Alliance / Cephalon Australia to use ImmunGene’s technology on six cancer targets / Strategic Transactions / Deal Date: Jan. 1, 2011 / Publish Date: Jan. 26, 2011

NextCure Inc. / See Company Profile

Financing / NextCure's IPO nets $80.2mm / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 10, 2019

Alliance / Lilly and NextCure pen immuno-oncology deal / Strategic Transactions / Deal Date: Nov. 1, 2018 / Update Date: May 1, 2019

Financing / NextCure closes $93mm Series B round / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 15, 2018

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Acelity LP Inc. / See Company Profile

Acquisition / 3M to buy Acelity; enterprise value $6.7bn / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 3, 2019

Acquisition / Acelity acquires Crawford Healthcare / Strategic Transactions / Deal Date: Jun. 1, 2018 / Publish Date: Jun. 12, 2018

Acquisition / Allergan acquires regenerative medicine company LifeCell / Strategic Transactions / Deal Date: Dec. 1, 2016 / Publish Date: Dec. 22, 2016

Ethicon Inc. / See Company Profile

Alliance / Takeda divests TachoSil to Ethicon / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 10, 2019

Acquisition / Advanced Sterilization Products to be acquired by Fortive for $2.7bn in cash / Strategic Transactions / Deal Date: Jun. 1, 2018 / Update Date: Apr. 1, 2019

Acquisition / Ethicon pays $3.4bn in cash for Auris Health / Strategic Transactions / Deal Date: Feb. 1, 2019 / Publish Date: Feb. 14, 2019

TransMedics Inc. / See Company Profile

Financing / Second IPO attempt successful for TransMedics; nets $97.4mm / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 3, 2019

Financing / Another late-stage round brings $51.2mm to TransMedics; $12.5mm added / Strategic Transactions / Deal Date: May 1, 2016 / Update Date: Jul. 1, 2016

Financing / Late-stage round brings $20mm to TransMedics / Strategic Transactions / Deal Date: Jun. 1, 2015 / Publish Date: Jun. 15, 2015

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Meridian Bioscience Inc. / See Company Profile

Acquisition / Meridian Bioscience buys GenePOC / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: May 6, 2019

Financing / PNC, Fifth Third provide Meridian Bio with up to $125mm in debt facility / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: May 6, 2019

Alliance / DiaSorin, Meridian sign second agreement for Liaison platform / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 24, 2018

Veracyte Inc. / See Company Profile

Financing / Public offering nets $138mm for Veracyte / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 7, 2019

Alliance / J&J, Veracyte ally in lung cancer diagnostics / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 15, 2019

Financing / Public offering nets $55.4mm for Veracyte / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 27, 2018

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Immunomedics Inc. / See Company Profile

Alliance / Everest Medicines licenses exclusive sacituzumab rights from Immunomedics / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 30, 2019

Alliance / Immunomedics to promote Janssen Biotech's erdafitinib in the US / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 30, 2019

Alliance / Immunomedics and AZ/MedImmune enter trial collaboration / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 24, 2018

Mitsubishi Tanabe Pharma Corp. / See Company Profile

Alliance / Salix gets rights to Mitsubishi Tanabe's MT1303 / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 30, 2019

Alliance / Mitsubishi Tanabe Pharma gets US rights to AnGes' Phase III Collategene; later expands rights / Strategic Transactions / Deal Date: Jul. 1, 2012 / Update Date: Apr. 1, 2019

Alliance / Mitsubishi Tanabe gets Japanese rights to Invossa from Kolon / Strategic Transactions / Deal Date: Nov. 1, 2016 / Update Date: Dec. 1, 2017

Mustang Bio Inc. / See Company Profile

Financing / Public offering nets $29.7mm for Mustang Bio / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: May 2, 2019

Financing / Mustang Bio enters $20mm venture debt financing with Horizon, gets $15mm up front / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 29, 2019

Alliance / Mustang Bio enters rare disease gene therapy space through partnership with St. Jude Children's / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Aug. 17, 2018

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel